Breast Cancer Care in Shanghai — World-Class Expertise for International Patients
Breast cancer is the most commonly diagnosed cancer in women worldwide. For international patients seeking advanced treatment in China, Shanghai offers access to internationally trained specialists, cutting-edge clinical protocols, and multidisciplinary oncology teams — all coordinated through China Medical Concierge Shanghai (CMCS).
Featured Specialist: Prof. Shen Kunwei (沈坤炜)
Prof. Shen Kunwei is one of China's foremost breast surgical oncologists, based at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine — consistently ranked among China's top hospitals for oncology.
Prof. Shen is the principal investigator of the landmark "Ruijin Protocol" (EC-TCb) clinical trial, a nationally recognized adjuvant chemotherapy regimen for early-stage triple-negative breast cancer (TNBC). Results from this research demonstrated:
- 34% reduction in postoperative recurrence risk
- 61% reduction in mortality risk
His team's work in early TNBC management is at the forefront of international oncology research, offering patients access to evidence-based protocols that are shaping global treatment standards.
Understanding Breast Cancer: Key Subtypes
Breast cancer is not a single disease. Treatment strategy depends heavily on the molecular subtype:
- Hormone receptor-positive (HR+/HER2−): The most common subtype; treated with endocrine therapy ± chemotherapy
- HER2-positive: Targeted therapy (trastuzumab, pertuzumab) combined with chemotherapy
- Triple-negative (TNBC): No hormone or HER2 receptors; historically harder to treat — now addressed by protocols like the Ruijin EC-TCb regimen and immunotherapy combinations
- Luminal B / high-grade: May require more aggressive systemic therapy
Treatment Approaches Available in Shanghai
Shanghai's leading breast cancer centers offer the full spectrum of evidence-based treatment:
- Breast-conserving surgery with oncoplastic reconstruction
- Sentinel lymph node biopsy to minimize axillary dissection
- Neoadjuvant chemotherapy to downstage tumors before surgery
- Adjuvant chemotherapy including the Ruijin EC-TCb protocol for TNBC
- Targeted therapy (HER2-directed agents)
- Immunotherapy (PD-1/PD-L1 inhibitors for eligible TNBC patients)
- Radiation oncology with image-guided precision techniques
- Genetic counseling for BRCA1/2 mutation carriers
Why International Patients Choose Shanghai
- Access to clinical trials and novel protocols not yet available in home countries
- Significantly lower treatment costs compared to the US, UK, or Singapore
- Multidisciplinary tumor boards with breast surgeons, medical oncologists, radiation oncologists, and pathologists
- Short waiting times for surgery and diagnostics
- English-speaking coordination through CMCS
How CMCS Supports Your Care
China Medical Concierge Shanghai (CMCS) is a health management company — not a hospital. We connect international patients with Shanghai's top breast cancer specialists, including Prof. Shen Kunwei at Ruijin Hospital, and manage every step of the process:
- Review of existing pathology reports, imaging, and biopsy results
- Specialist matching based on subtype, stage, and treatment history
- Appointment scheduling and medical document translation
- Accompaniment and interpretation during consultations
- Post-treatment follow-up coordination
Get in Touch
If you or a family member has been diagnosed with breast cancer and are considering treatment in Shanghai, contact our team for a confidential consultation.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 commenti